Skip to main content
The Egyptian Journal of Internal Medicine

Table 2 Clinical trials of non-JAK targeted drugs for myelofibrosis

From: Myelofibrosis treatment history and future prospects

Inhibitor

Phase

Reference

Alisertib

I

[30]

Imetelstat

II

[31]

Pembrolizumab

II

[32]

Nivolumab

II

[33]

Sotatercept

II

[34]

Back to article page